PacBio (@pacbio) 's Twitter Profile
PacBio

@pacbio

Our mission is to enable the promise of #genomics to better human health by creating the world’s most advanced #sequencing technologies. #PacBio

ID: 39694489

linkhttp://www.pacb.com calendar_today13-05-2009 05:18:38

27,27K Tweet

44,44K Followers

2,2K Following

PacBio (@pacbio) 's Twitter Profile Photo

We’ve kicked off our Spotlight Theater session at #AACR25! 🎯 Join #PacBio as we explore how highly accurate long-read sequencing is opening a new day in cancer variant discovery—revealing critical insights missed by short-read methods. Stay tuned for more!

We’ve kicked off our Spotlight Theater session at #AACR25! 🎯   Join #PacBio as we explore how highly accurate long-read sequencing is opening a new day in cancer variant discovery—revealing critical insights missed by short-read methods. Stay tuned for more!
PacBio (@pacbio) 's Twitter Profile Photo

Alex Sockell, PhD, from #PacBio is now live at #AACR25!  She shares how sequencing FFPE samples with PacBio enables better phasing to determine cis vs. trans mutations and improves structural variant (SV) calling.

Alex Sockell, PhD, from #PacBio is now live at #AACR25!   She shares how sequencing FFPE samples with PacBio enables better phasing to determine cis vs. trans mutations and improves structural variant (SV) calling.
PacBio (@pacbio) 's Twitter Profile Photo

Bingqing Zhao, PhD, from Stanford University takes the stage at #AACR25 to share how long-read sequencing uncovered a novel structural variant in the FBXW7 gene—a gene mutated in up to 18% of colorectal cancer (CRC) patients. #PacBio

Bingqing Zhao, PhD, from Stanford University takes the stage at #AACR25 to share how long-read sequencing uncovered a novel structural variant in the FBXW7 gene—a gene mutated in up to 18% of colorectal cancer (CRC) patients. #PacBio
PacBio (@pacbio) 's Twitter Profile Photo

Bingqing continues her presentation, highlighting how the percentage of novel isoforms increases as tissue progresses from normal, to benign polyp, to dysplastic polyp, and ultimately to cancer. #AACR25 #PacBio

Bingqing continues her presentation, highlighting how the percentage of novel isoforms increases as tissue progresses from normal, to benign polyp, to dysplastic polyp, and ultimately to cancer. #AACR25 #PacBio
PacBio (@pacbio) 's Twitter Profile Photo

Arthur Dondi, PhD, from ETH Zürich is now presenting at #AACR25! He shares how cancer cells express the IGF1 class II isoform, while normal cells express class I. The secreted class II promotes growth of neighboring cells—an important distinction revealed by long-read

Arthur Dondi, PhD, from ETH Zürich is now presenting at #AACR25!  He shares how cancer cells express the IGF1 class II isoform, while normal cells express class I. The secreted class II promotes growth of neighboring cells—an important distinction revealed by long-read
PacBio (@pacbio) 's Twitter Profile Photo

Arthur continues, showcasing how long-read sequencing discovered a novel fusion in an ovarian cancer patient—one that short-read methods miscalled as simple overexpression of the 3' fusion partner. #AACR25 #PacBio

Arthur continues, showcasing how long-read sequencing discovered a novel fusion in an ovarian cancer patient—one that short-read methods miscalled as simple overexpression of the 3' fusion partner. #AACR25 #PacBio
PacBio (@pacbio) 's Twitter Profile Photo

Thank you to everyone who attended our Spotlight Theater session today at #AACR25! It was inspiring to explore how #PacBio sequencing is enabling deeper insights into cancer biology and advancing discovery across the field. Stay connected as we continue to push the boundaries

Thank you to everyone who attended our Spotlight Theater session today at #AACR25! 

It was inspiring to explore how #PacBio sequencing is enabling deeper insights into cancer biology and advancing discovery across the field. Stay connected as we continue to push the boundaries
PacBio (@pacbio) 's Twitter Profile Photo

DNA or RNA—where do you stand? 🧬🧫 Visit #PacBio booth #1042 at #AACR25 to cast your vote by dropping a ticket in the jar. Each vote enters you into a raffle to win Bose headphones. 🎧 Science gets competitive—don’t miss it!

DNA or RNA—where do you stand? 🧬🧫 

Visit #PacBio booth #1042 at #AACR25 to cast your vote by dropping a ticket in the jar. Each vote enters you into a raffle to win Bose headphones. 🎧 

Science gets competitive—don’t miss it!
PacBio (@pacbio) 's Twitter Profile Photo

Step into the future of cancer research at #AACR25 with our interactive touchscreen at #PacBio Booth #1042! 🧬 Discover how #PacBio is helping scientists decode cancer—one genome or transcriptome at a time. Tap, swipe, and explore breakthroughs driving the next era of

Step into the future of cancer research at #AACR25 with our interactive touchscreen at #PacBio Booth #1042! 🧬 
 
Discover how #PacBio is helping scientists decode cancer—one genome or transcriptome at a time. 
 
Tap, swipe, and explore breakthroughs driving the next era of
PacBio (@pacbio) 's Twitter Profile Photo

Don’t forget to sign up for the #PacBio Quest at #AACR25! 🔍 Compete for exclusive prizes while exploring the conference and connect with fellow attendees. Sign up now: bit.ly/3YfRZuO Have questions? Visit us at Booth #1042!

Don’t forget to sign up for the #PacBio Quest at #AACR25! 🔍 Compete for exclusive prizes while exploring the conference and connect with fellow attendees. 

Sign up now: bit.ly/3YfRZuO 

Have questions? Visit us at Booth #1042!
PacBio (@pacbio) 's Twitter Profile Photo

🥁 Drum roll please... Huge congratulations to Team Apollo for winning our first-ever PRISM Break Scavenger Hunt! Teamwork, creativity, and lots of laughter make any challenge possible. #PacBioPRISM

PacBio (@pacbio) 's Twitter Profile Photo

Today is your last chance to visit #PacBio at booth #1042 at #AACR25—stop by before 12 PM to enter our raffle for Bose headphones, explore our interactive touchscreen, and see how we’re helping researchers uncover critical variants others miss.

Today is your last chance to visit #PacBio at booth #1042 at #AACR25—stop by before 12 PM to enter our raffle for Bose headphones, explore our interactive touchscreen, and see how we’re helping researchers uncover critical variants others miss.
PacBio (@pacbio) 's Twitter Profile Photo

Hear Sukhvinder Nicklen, PhD introduce what Day Two of #PacBioPRISM had in store and how it sparked many great conversations, discussions, and key learnings about the boundless possibilities of #HiFisequencing. #PacBio #RareDisease

PacBio (@pacbio) 's Twitter Profile Photo

Thanks to everyone who stopped by the #PacBio booth at #AACR25! It was a great week of conversations around cancer research, long-read sequencing, and what’s next for HiFi. We’re proud to be part of the progress.

Thanks to everyone who stopped by the #PacBio booth at #AACR25! It was a great week of conversations around cancer research, long-read sequencing, and what’s next for HiFi. We’re proud to be part of the progress.
PacBio (@pacbio) 's Twitter Profile Photo

We’re proud to announce the PacBio Compatible partners sponsoring #PacBioPRISM 2025 in San Francisco and Boston. If you’re attending, don’t miss the chance to connect with these industry leaders onsite and explore how their technologies support and enhance #PacBio sequencing.

We’re proud to announce the PacBio Compatible partners sponsoring #PacBioPRISM 2025 in San Francisco and Boston.

If you’re attending, don’t miss the chance to connect with these industry leaders onsite and explore how their technologies support and enhance #PacBio sequencing.
PacBio (@pacbio) 's Twitter Profile Photo

PRISM 2025 in Athens is a wrap! Huge thanks to everyone who joined us — together we're shaping the future of genomics. 👏 Congrats to all our award winners! Here’s to more innovation, collaboration & discovery. #PacBioPRISM

PacBio (@pacbio) 's Twitter Profile Photo

#PacBio APAC and our sales channel partners reunited in Da Nang for the 2025 Channel Odyssey. After two years, it was great to return to the Village of Hope, bringing smiles and special treats. Looking forward to more collaboration with our partners this year!